NCT00567177View on ClinicalTrials.gov

Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2007

Study Completion Date

April 30, 2008

Conditions
Treatment of Dry Eye Disease
Interventions
DRUG

Restasis, Refresh Plus

Restasis 0.4ml- (in the eye) Instill one drop twice daily in morning and evening Refresh Plus 0.4ml- (in the eye) Instill one drop twice daily in morning and evening

Trial Locations (1)

77030

Hermann Eye Center, 6400 Fannin Ste 1800

Sponsors

Lead Sponsor

Innovative Medical
All Listed Sponsors
lead

Innovative Medical

INDUSTRY

NCT00567177 - Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease | Biotech Hunter | Biotech Hunter